BIOCON price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- BIOCON
- MB Code
- MBEQU2741
- ISIN
- INE376G01013
- BSE code
- 532523
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 4516.6 Cr
- Net profit
- 198.6 Cr
- EPS
- 0.79
- YoY revenue
- +2.25%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for BIOCON
Dividend of ₹0.50 per share
Ex-date corporate action
Biocon says biosimilars traction in the US and merger-led synergies should aid margins through FY27, with nearly ₹300 crore interest-cost…
EPS 1.29 vs est. 1.20
Beat estimates by 7.33%
Biocon shares fell over 3% on Friday, March 27 after CEO & MD Siddharth Mittal resigned; company said he will transition to a new role, p…
Biocon said it received US FDA approval for its Liraglutide Injection, a complex formulation for chronic weight management, enabling the …
EPS 2.75 vs est. 1.22
Beat estimates by 125.02%
Biocon reported consolidated Q3 (ended Dec 2025) net profit of Rs 144 crore vs Rs 25 crore year‑ago; revenue Rs 4,173 crore. Board approv…
On Feb 1, 2026, Finance Minister Nirmala Sitharaman proposed a Rs 10,000 crore investment in the biopharma sector, boosting stocks of Ant…
Price returns
Historical performance
Technicals
Indicator consensus